467 related articles for article (PubMed ID: 18485763)
1. Genetic defects in von Willebrand disease type 3 in Indian and Greek patients.
Gupta PK; Saxena R; Adamtziki E; Budde U; Oyen F; Obser T; Schneppenheim R
Blood Cells Mol Dis; 2008; 41(2):219-22. PubMed ID: 18485763
[TBL] [Abstract][Full Text] [Related]
2. New mutations in exon 28 of the von Willebrand factor gene detected in patients with different types of von Willebrand's disease.
Casaña P; Martínez F; Haya S; Tavares A; Aznar JA
Haematologica; 2001 Apr; 86(4):414-9. PubMed ID: 11325649
[TBL] [Abstract][Full Text] [Related]
3. Gene conversions are a common cause of von Willebrand disease.
Gupta PK; Adamtziki E; Budde U; Jaiprakash M; Kumar H; Harbeck-Seu A; Kannan M; Oyen F; Obser T; Wedekind I; Saxena R; Schneppenheim R
Br J Haematol; 2005 Sep; 130(5):752-8. PubMed ID: 16115133
[TBL] [Abstract][Full Text] [Related]
4. Genetic mutations in von Willebrand disease identified by DHPLC and DNA sequence analysis.
Kakela JK; Friedman KD; Haberichter SL; Buchholz NP; Christopherson PA; Kroner PA; Gill JC; Montgomery RR; Bellissimo DB
Mol Genet Metab; 2006 Mar; 87(3):262-71. PubMed ID: 16321553
[TBL] [Abstract][Full Text] [Related]
5. Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients.
Yadegari H; Driesen J; Pavlova A; Biswas A; Hertfelder HJ; Oldenburg J
Thromb Haemost; 2012 Oct; 108(4):662-71. PubMed ID: 22871923
[TBL] [Abstract][Full Text] [Related]
6. Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1.
Schneppenheim R; Budde U; Krey S; Drewke E; Bergmann F; Lechler E; Oldenburg J; Schwaab R
Thromb Haemost; 1996 Oct; 76(4):598-602. PubMed ID: 8903002
[TBL] [Abstract][Full Text] [Related]
7. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the genetic defects in recessive type 1 and type 3 von Willebrand disease patients of Italian origin.
Eikenboom JC; Castaman G; Vos HL; Bertina RM; Rodeghiero F
Thromb Haemost; 1998 Apr; 79(4):709-17. PubMed ID: 9569178
[TBL] [Abstract][Full Text] [Related]
9. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the von Willebrand factor gene (VWF) in von Willebrand disease type III patients from 24 families of Swedish and Finnish origin.
Zhang ZP; Blombäck M; Egberg N; Falk G; Anvret M
Genomics; 1994 May; 21(1):188-93. PubMed ID: 8088787
[TBL] [Abstract][Full Text] [Related]
11. Understanding von Willebrand's disease from gene defects to the patients.
Zhang Z; Blombäck M; Anvret M
J Intern Med Suppl; 1997; 740():115-9. PubMed ID: 9350192
[TBL] [Abstract][Full Text] [Related]
12. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
[TBL] [Abstract][Full Text] [Related]
13. von Willebrand disease: a database of point mutations, insertions, and deletions. For the Consortium on von Willebrand Factor Mutations and Polymorphisms, and the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
Ginsburg D; Sadler JE
Thromb Haemost; 1993 Feb; 69(2):177-84. PubMed ID: 8456431
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of a multiethnic group of 21 patients with type 3 von Willebrand disease.
Baronciani L; Cozzi G; Canciani MT; Peyvandi F; Srivastava A; Federici AB; Mannucci PM
Thromb Haemost; 2000 Oct; 84(4):536-40. PubMed ID: 11057846
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of type 2N von Willebrand disease using phenotypic and molecular techniques.
Nesbitt IM; Goodeve AC; Guilliatt AM; Makris M; Preston FE; Peake IR
Thromb Haemost; 1996 Jun; 75(6):959-64. PubMed ID: 8822593
[TBL] [Abstract][Full Text] [Related]
16. [Study on genetic mutations of the vWF in type 2A von Willebrand disease].
Wang Y; Zhang J; Zhang W; Cheng D; Wan H; Ruan C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Aug; 17(4):229-32. PubMed ID: 10932002
[TBL] [Abstract][Full Text] [Related]
17. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of inherited von Willebrand disease: a clinical perspective.
Federici AB
Semin Thromb Hemost; 2006 Sep; 32(6):555-65. PubMed ID: 16977566
[TBL] [Abstract][Full Text] [Related]
19. Mutations in von Willebrand factor multimerization domains are not a common cause of classical type 1 von Willebrand disease.
Keeney S; Cumming A; Hay C
Thromb Haemost; 1999 Nov; 82(5):1446-50. PubMed ID: 10595636
[TBL] [Abstract][Full Text] [Related]
20. Expression studies of missense mutations p.D141Y, p.C275S located in the propeptide of von Willebrand factor in patients with type 3 von Willebrand disease.
Baronciani L; Federici AB; Cozzi G; La Marca S; Punzo M; Rubini V; Canciani MT; Mannucci PM
Haemophilia; 2008 May; 14(3):549-55. PubMed ID: 18328061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
